NEWS & EVENTS » NEWS » ALL
NEWS
25/06/2020
Corporate

Z43 Goes Carbon Dioxide-Free

As part of our effort to help create a sustainable and healthier future, energy at Z43 is now 100% renewable, which will lead to a reduction in CO2 emissions of more than 60,000 m3 per year – corresponding to about twenty times the CO2 footprint of the average Swiss.

For the past 20 years, we have produced the heating energy for the Z43 headquarters in Zurich – home to the IT’IS Foundation, Schmid & Partner Engineering AG, and ZMT Zurich MedTech AG – as well as supplied adjacent residential buildings with more than 79 apartments with natural gas. Our labs, on the other hand, were cooled via a small heat pump powered by electricity. Though gas is “cleaner” than oil or coal, we strongly felt that it was time to switch from fossil fuels to renewable sources of power in order to run our work lives more sustainably.

niels roof panels web

niels basement heating web

So we finally got rid of the gas burners in our basement and invested heavily in a new energy system. The newly installed 500 kW heat pump now heats and cools the various buildings by exchanging heat with the groundwater stream that runs 30 m below our premises. In addition, because our labs and servers produce more heating energy than we can use during the summer, we replaced the warm-water panels on the roof with photovoltaic cells to generate our electric power. We also took care to only subscribe to companies that exclusively generate electricity by hydro, wind, and solar power. This complements our internal policy that Z43 staff should only commute by car to work in exceptional circumstances (e.g., it was appropriate to do so during the COVID-19 pandemic).

We are proud that we have started to generate our own energy and have become largely CO2-free at Z43.

Curious how it looks? Check out our CO2-free energy production by clicking on the leaf:

leaf slogan mm3

The leaf can also be found in the header of any of our webpages: IT’IS Foundation, SPEAG, ZMT, and Zurich43.

Z43 – Think Renewable!

Sim4Life

06/09/2012

Contact
info@zmt.swiss

 

ZMT sponsors the ISMRM 2012 Safety Workshop

ZMT will sponsor this year's ISMRM Safety Workshop in Lund, Sweden (Sept. 5-9, 2012).

 
Sim4Life

01/05/2012

Contact
info@zmt.swiss

 

ZMT@ISMRM 2012

Zurich MedTech was a sponsor of the ISMRM 2012 Annual Meeting in conjunction with SPEAG.  Solution-specific solutions for MRI R&D engineers and clinicians were presented. We look forward to further developing our large portfolio technology to meet the needs of the MRI community.

 
Sim4Life

28/11/2011

Contact
info@zmt.swiss

 

ZMT @ RSNA 2011

We will be presenting and demonstrating our latest innovations in the field of Active Implantable Medical Devices safety testing, cancer treatment planning and hyperthermia cancer treatment. Meet us for solution-specific discussions with our R&D engineers. We look forward to answering your product related questions and providing you with the latest information as well as an outlook towards forthcoming poduct developments.

 
Corporate

04/10/2011

Contact
info@zmt.swiss

 

Tissues Properties Database Online

We are pleased to announce the availability of the Tissues Properties Database, a comprehensive and accurate reference database of the thermal and dielectric properties of biological tissues.

 
Sim4Life

15/08/2011

Contact
info@zmt.swiss

 

ZMT releases Sim4Life SEMCAD X MRI

Sim4Life SEMCAD X MRI is released!

 
Sim4Life

01/05/2011

Contact
info@zmt.swiss

 

ISMRM 2011 Annual Meeting

Once again ZMT will be at the ISMRM Annual Meeting presenting our latest solutions and innovations in MRI RF safety testing of Active Implantable Medical Devices. Meet us for solution specific discussions and product related questions. 

 
Validation HW

15/04/2011

Contact
info@zmt.swiss

 

MITS1.5/MITS3.0 Successfully Installed at FDA

We are proud to announce the successful installation of our MITS1.5/MITS3.0 implant test systems at the Food and Drug Administration Center for Devices and Radiological Health  (FDA-CDRH).

 

 
Page 18 of 19